Leading Robotic Prostate Surgery Clinic in Spain

The surgeon operating the Robot

This superb clinic is based in Gran Canaria. It was founded in 2018 with the mission of providing minimally invasive urological surgery at the highest standards.

Since then, it has become a reference point in the Canary Islands and Spain for laser and robotic prostate procedures

After years of training and working in renowned centers in Barcelona and London, the Urologist realised the need to consolidate high-level surgical techniques — particularly laser and robotic surgery — into one specialised center.

The clinic was founded with that vision: to combine precision medicine, cutting-edge technology, and personalised care.

All the senior medical staff speak fluent English. They also have team members who speak German and French, ensuring patients can communicate clearly and comfortably throughout their treatment.

The head Urologist has over 20 years of experience in urology and prostate surgery, with extensive specialisation in both traditional and laser-assisted procedures

The core focus is minimally invasive treatment of prostate conditions, including benign prostatic hyperplasia (BPH) and localised prostate cancer.

He specialises in HoLEP (Holmium Laser Enucleation) and robotic-assisted radical prostatectomy using the Hugo™ RAS system.

The surgical team preparing for Robotic surgery

They offer a wide range of urological treatments, including robotic surgery, laser surgery, diagnosis and treatment of prostate diseases, kidney stones, erectile dysfunction, among others

They mainly treat BPH, early-stage prostate cancer, and prostatitis. Many patients also choose them for second opinions or to access laser surgery when other centers suggest more invasive options

Many centers still follow a one-size-fits-all surgical path.

Here, they start by understanding the patient’s functional needs, lifestyle and concerns.

Then they match them with the least invasive option that still guarantees full clinical efficacy—be it laser enucleation or robotic prostatectomy.

They're also early adopters of new protocols like same-day discharge, and they use intraoperative digital tools to ensure precision and reduce risks.

The result is faster recovery, better urinary outcomes, and often, preserved sexual function.

Surgery lasts around 90 to 120 minutes.

Most patients are discharged within 24–48 hours. They typically recommend a stay on the island for 5–7 days, allowing for follow-up before flying home

Success rates are very high. For HoLEP, functional results are excellent with minimal bleeding and re-intervention.

In robotic prostatectomy, they achieve strong oncological and functional outcomes, comparable to leading European institutions.

Robotic Surgery has many advantages for the patient

Benefits of Prostate Laser Surgery:

Less bleeding, no incisions, quicker discharge, effective relief of symptoms, suitability for patients on blood thinners and it is also associated with a lower risk of sexual side effects compared to traditional procedures.

This clinic combines the precision of a top-tier surgical center with the warmth and accessibility of personalised medicine.

Patients receive direct attention from experienced surgeons—not intermediaries—and benefit from technologies like the Hugo™ robotic system and advanced lasers.

What is Benign Prostatic Hyperplasia (BPH)? 

Benign Prostatic Hyperplasia (BPH) is a common condition that affects men over the age of 50.

As men age, the prostate gland may enlarge, leading to urinary symptoms such as increased frequency (especially at night), difficulty initiating urination, weak or intermittent urinary stream, urgency, urinary incontinence, and pelvic discomfort. In more severe cases, urinary retention may occur, requiring the use of a catheter.

These symptoms can significantly impair a patient’s quality of life.
In the early stages, symptoms may be managed with medication; however, over time, approximately 20–30% of patients will eventually require surgical intervention.

What is HoLEP- TuLEP (Holmium/tulium Laser Enucleation of the Prostate)? 

HoLEP is the most advanced minimally invasive surgical technique for treating BPH.

It involves no external incisions or scarring, as the procedure is performed entirely through the urethra. Using a holmium laser, the prostate tissue (adenoma) causing obstruction is precisely separated from the prostate capsule and removed in its entirety.

There is no limitation regarding prostate size for this procedure (applicable for glands ranging from 20 to 500 grams), making it suitable for nearly all patients. Due to the technical complexity and the need for specialised equipment, HoLEP should only be performed in highly experienced centers.

How does the procedure work? 

The holmium laser is used to enucleate the adenomatous prostate tissue from the surrounding capsule in a controlled, anatomical manner. Once detached, the tissue is pushed into the bladder and fragmented using a specialised instrument called a morcellator, which allows the pieces to be extracted.

This process avoids burning the tissue and enables simultaneous coagulation of blood vessels encountered during the procedure, minimising bleeding.

All removed tissue is collected for pathological examination to rule out hidden prostate cancer. After enucleation, morcellation, and tissue removal, final hemostasis is carefully performed to ensure a safe and comfortable recovery. The surgery concludes with the placement of a bladder catheter with continuous irrigation.

Benefits of HoLEP Surgery

● Minimally Invasive Procedure:  Performed endoscopically through the urethra, with no external incisions or scarring. 
● Fast Recovery:  Most patients can be discharged within 24 hours post-surgery. 
● Minimal Catheterisation Time:  The bladder catheter typically remains in place for just 1–2 days. 
● Superior Continence Outcomes:  En bloc enucleation significantly reduces the risk of postoperative incontinence to below 0.5%, outperforming many other surgical techniques. 
● Minimal Bleeding Risk:  Safe for patients on anticoagulants, those with heart valve prostheses, or other bleeding disorders, provided proper preoperative management is followed. 
● Rapid Return to Daily Activities:  Mild urinary discomfort may be present initially, but patients usually resume work within one week and physical activity within 10–15 days.